NCT06732791 (MGAP-GAP) is a clinical trial in Trauma, sponsored by Al-Nahrain University.

Who is sponsoring NCT06732791?

NCT06732791 is sponsored by Al-Nahrain University.

Is NCT06732791 still recruiting?

NCT06732791 is currently recruiting now. Last updated 4 March 2026.

Last reviewed 2026-03-04 · How we verify

NCT06732791: MGAP-GAP

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparative Analysis of MGAP and GAP Trauma Scores in Predicting Outcomes for Multiple Trauma Patients

Recruiting now Last updated 4 March 2026

What this trial tests

trial in Trauma in 522 participants. Currently enrolling.

Timeline

20 January 2025

Primary endpoint
10 March 2027

20 March 2027

Quick facts

Lead sponsor	Al-Nahrain University
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	522
Start date	20 January 2025
Primary completion	10 March 2027
Estimated completion	20 March 2027
Sites	1 location across Iraq

Conditions studied

Trauma — all drugs for Trauma →

Sponsor

Al-Nahrain University

Who can join

16 and older, any sex, with Trauma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this prospective cohort study is to compare the predictive accuracy of the MGAP and GAP trauma scores in determining the prognosis of multiple trauma patients admitted to the emergency department at Al-Kadhimiya Teaching Hospital, Iraq. The main questions it aims to answer are: Does the MGAP score provide a more accurate prediction of outcomes compared to the GAP score? Are there specific subgroups of trauma patients where one score demonstrates superior predictive utility over the other? Participants will: Be assessed using both the MGAP and GAP scores upon admission to the emergency department. Have their clinical outcomes, including mortality, length of stay, and need for surgery, tracked throughout their hospital stay.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

A comparative evaluation of the prognostic performance of MGAP and GAP trauma scores in predicting clinical outcomes in multiple trauma patients: protocol for a prospective cohort study from Baghdad, Iraq.
Khamees AR, Gomaa AA, Mahgoub AMA, Abotaleb SJ, et al · · 2026 · PMID 42049304 · DOI 10.1136/bmjopen-2025-105628

Verify or expand the search:

Other recruiting trials for Trauma

Currently open trials in the same condition.

NCT07290634 — Comparative Outcomes of PCC and Recombinant Activated Factor VIIa in Trauma-Associated Massive Transfusion · recruiting
NCT07485231 — Nitric Oxide (NO) and Endothelial Dysfunction in Women With PTSD · NA · recruiting
NCT07473336 — The Effectiveness of RAPID-Based Psychological First Aid Training · NA · active not recruiting
NCT07278505 — Study of Cannabidiol and Neuroimaging on Stress · Phase 1, PHASE2 · recruiting
NCT02880163 — REVIVE: Reducing Exsanguination Via In-Vivo Expandable Foam · NA · recruiting

Other Al-Nahrain University trials

Trials by the same sponsor.

NCT07437664 — A Computer-Aided Design Approach for Customized Soft Transradial Prosthetic Sockets Using 3D Scanning · NA · active not recruiting
NCT07186777 — Comparison of EMTRAS, REMS, and GAP Scores in Trauma · recruiting
NCT06744959 — Thorax Trauma Severity Score in Chest Trauma: A Study in Iraq · recruiting
NCT06705959 — Comparing NISS and ISS for Mortality Prediction in Trauma Patients · recruiting
NCT06732752 — Evaluating the New Trauma Score (NTS) for Improved Mortality Prediction · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06732791 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Al-Nahrain University
Last refreshed: 4 March 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06732791.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing